Royal Bank of Canada’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

Royal Bank of Canada’s Portfolio MRNY Stock Details MRNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-41	Closed	-$6K	–	7213
2024 Q2	$6K	Buy	41 +3	+8%	+$591	﹤0.01%	6490
2024 Q1	$8K	Buy	+38	New	+$7.78K	﹤0.01%	6284

Other funds holding MRNY

Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

TAM

Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada's MRNY Position: Q3 2024 in Review

Royal Bank of Canada sold out of YieldMax MRNA Option Income Strategy ETF (MRNY) in Q3 2024, closing a stake of 41 shares — an estimated $6K sold.

Royal Bank of Canada first reported a position in MRNY in Q1 2024 and held it in 2 quarters. The position peaked at $8K in Q1 2024. 3 funds tracked by Wall St. Rank hold MRNY as of Q3 2024.

Royal Bank of Canada reported no remaining YieldMax MRNA Option Income Strategy ETF position as of Q3 2024 after selling out during the quarter.
Royal Bank of Canada sold 41 YieldMax MRNA Option Income Strategy ETF shares in Q3 2024, an estimated $6K.
Royal Bank of Canada first reported a position in YieldMax MRNA Option Income Strategy ETF in Q1 2024 and held it in 2 quarters.
Royal Bank of Canada's YieldMax MRNA Option Income Strategy ETF position peaked at $8K in Q1 2024.
3 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.